MoneyWorks4Me

The sales declined to Rs. 705.66 millions for the June 2025 quarter as compared to Rs. 893.56 millions during the corresponding quarter last year.The Company to register a -57.88%  fall in the net profit for the quarter ended June 2025.Operating Profit reported a sharp decline to 113.82 millions from 239.40 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 705.66 893.56 -21.03 705.66 893.56 -21.03 3457.68 3624.62 -4.61
Other Income 220.36 230.62 -4.45 220.36 230.62 -4.45 295.81 575.52 -48.60
PBIDT 113.82 239.40 -52.46 113.82 239.40 -52.46 326.07 1044.32 -68.78
Interest 5.55 0.93 496.77 5.55 0.93 496.77 4.10 3.21 27.73
PBDT 108.27 238.47 -54.60 108.27 238.47 -54.60 321.97 1041.11 -69.07
Depreciation 23.89 17.85 33.84 23.89 17.85 33.84 69.69 68.25 2.11
PBT 84.38 220.62 -61.75 84.38 220.62 -61.75 252.28 972.86 -74.07
TAX 5.01 32.18 -84.43 5.01 32.18 -84.43 80.27 218.66 -63.29
Deferred Tax 5.01 20.36 -75.39 5.01 20.36 -75.39 21.03 42.76 -50.82
PAT 79.37 188.44 -57.88 79.37 188.44 -57.88 172.01 754.20 -77.19
Equity 57.07 57.07 0.00 57.07 57.07 0.00 57.07 57.07 0.00
PBIDTM(%) 16.13 26.79 -39.80 16.13 26.79 -39.80 9.43 28.81 -67.27

Albert David Share Price

836.60 0.00 (0.00%)
19-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1910.00
Dr. Reddys Labs. 1171.75
Cipla 1443.60
Lupin 2243.05
Zydus Lifesciences 1112.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: